Genome-wide analysis has revealed that global DNA methylation levels are reduced by 15%–20% in the CD4+ T cells of patients with active SLE (48), especially genes involved in disease pathogenesis and progression, such as ITGAL, CD40LG, CD70, and PPP2CA. The gene discussed is ITGAL; the disease is systemic lupus erythematosus.